Me + C3G educational campaign

These educational resources were developed as part of the American Kidney Fund's "Me + C3G," its educational campaign for the rare kidney disease complement 3 glomerulopathy (C3G). Developed with financial support from Novartis Pharmaceuticals Corporation (Novartis), these resources expand the campaign and provide patients and their families with more information about C3G to help them better understand and manage this rare kidney disease.

C3G is a type of kidney disease that is related to improper function of the immune system. With C3G, a part of the immune system called the complement system becomes overactive and doesn't work properly, leading to damage and inflammation in the kidneys. This damage prevents the kidneys from filtering toxins out of the blood and can cause kidney failure in about half of adults who are diagnosed with the disease.

Because C3G is typically diagnosed in children and young adults, AKF has developed new resources to help manage the pediatric to adult transition for C3G patients as part of its expanded educational campaign.